Immediate Impact
57 standout
Citing Papers
Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
2024 Standout
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
2023 Standout
Works of Nam-Su Lee being referenced
Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer.
2012
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nam-Su Lee | 149 | 114 | 45 | 86 | 46 | 332 | |
| Rika Kasajima | 132 | 124 | 67 | 123 | 37 | 334 | |
| Hun-Mo Ryoo | 102 | 105 | 95 | 46 | 30 | 291 | |
| Hari A. Deshpande | 133 | 119 | 31 | 40 | 44 | 355 | |
| Başak Oyan | 151 | 67 | 28 | 32 | 38 | 337 | |
| Yasuhiro Arakawa | 156 | 147 | 20 | 91 | 38 | 370 | |
| Hiroto Horiguchi | 117 | 92 | 70 | 50 | 27 | 313 | |
| Ender Kurt | 214 | 66 | 32 | 71 | 32 | 368 | |
| Min Yang | 82 | 84 | 35 | 41 | 27 | 356 | |
| Kelsey Klute | 159 | 124 | 22 | 55 | 25 | 329 | |
| Thangam Arumugham | 161 | 129 | 44 | 36 | 29 | 351 |
All Works
Login with ORCID to disown or claim papers
Loading papers...